Novo Nordisk's Wegovy cuts risk of heart attack, stroke by 20%, study finds
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say
Source: marketwatch.com
Stay updated with breaking news from Anna Windle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say
/PRNewswire/ -- Novo Nordisk today announced the upcoming presentation of new data that helps reinforce the company's commitment to driving change and...